Cerebral Therepeutics

In The Know: Healthcare News for November 23, 2020

B2 Mask Named to TIME’s List of 100 Best Inventions of 2020 BARDA Expands Partnership with DiaSorin Inc to Develop an Enhanced IgG Assay for Determining COVID-19 Patient Exposure and Immune Status Joe Biden’s Plan for COVID-19 and How the Industry is Reacting 3M Announces James Momon as Vice President, Equity & Community and Chief […]

Cerebral Therapeutics Announces Enrollment of First Patient in a Multicenter Randomized Controlled Phase 2b Trial in Epilepsy

Study builds on published results of initial trial in refractory epilepsy patients AURORA, Colo.–(BUSINESS WIRE)–Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, today announced that the first patient has been enrolled in a Phase 2b study of intracerebroventricular drug delivery of the anti-seizure medication CT-010 in patients with medically refractory […]

In The Know: Healthcare News for November 16, 2020

Mayo Clinic Establishes New Grant Fund for Racial Equity Medibio Partners with US Company for New Clinical Trial FDA clears Apple Watch Sleep App that Intervenes to Stop Nightmares Caused by PTSD Community Learning Pods Get Boost with Allina Health Office Space Donation Aldevron Names Shawn McCormick Chief Financial Officer Osterholm Asked to Join Biden’s […]

In the Know: Healthcare News for Jan. 20, 2020

Medtronic wins 2020 Catalyst Award FDA-approved clinical trial to study expanded use of Abbott’s MitraClip Smiths Medical launches Portex tracheostomy tubes and kits Mayo Clinic launches its first Platform initiative Cerebral Therapeutics Completes $35 Million Series B Financing Tactile Medical CEO announces retirement in 2020 Medtronic receives CE Mark for neurostimulators for urology treatment Flannel […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER